PSMA4

PSMA4 is a proteasome alpha-type subunit that functions as a docking point for ubiquitin-independent proteasomal degradation, coupling protein turnover to metabolic signaling (PMID:37116777). In adipocytes, PSMA4 binds directly to ISLR, and this interaction drives ubiquitin-independent degradation of the insulin receptor alpha subunit; loss of ISLR raises INSRα levels and improves insulin sensitivity in obese mice, placing PSMA4 within the control of insulin signaling (PMID:37116777). Beyond this characterized role, the available corpus provides no structural model of PSMA4 or definition of how target specificity is achieved.

1. 2014 Low

   An unbiased screen for binding partners of the saffron carotenoid crocin first physically linked PSMA4 to a small-molecule ligand, providing an early biochemical handle on the protein.

   Evidence crocin-agarose affinity chromatography with 2D PAGE and MALDI-TOF/TOF mass spectrometry

   PMID:24393168

   Open questions at the time

   • Single affinity pulldown identifying many proteins with no functional follow-up for PSMA4
   • Does not establish any cellular or proteasomal function
   • No demonstration that crocin binding alters PSMA4 activity
2. 2023 Medium

   Identification of a direct PSMA4–ISLR interaction established PSMA4 as a docking subunit for ubiquitin-independent degradation of the insulin receptor, mechanistically connecting the proteasome to insulin sensitivity.

   Evidence Co-immunoprecipitation, ISLR siRNA knockdown in white adipose tissue, and ISLR knockout mice with INSRα quantification and insulin sensitivity assays

   PMID:37116777

   Open questions at the time

   • Structural basis of ISLR recognition and the route of INSRα entry into the proteasome unresolved
   • Whether PSMA4 contributes target specificity or acts as a generic docking site is unknown
   • Single-lab study
3. 2024 Low

   A second metabolic partner, TIR8, was found to bind PSMA4 under lipotoxic conditions, extending PSMA4-mediated degradation to hepatic lipid metabolism and PPARα regulation.

   Evidence Mass spectrometry interaction screen in TIR8 knockout mice with ectopic TIR8 expression and FFA stimulation assays

   PMID:38851532

   Open questions at the time

   • Interaction derived from a mass spectrometry screen with limited mechanistic follow-up
   • Proteasomal route of TIR8 degradation inferred rather than directly demonstrated
   • No reciprocal validation of the PSMA4–TIR8 interaction reported

• It remains unknown how PSMA4 selects its degradation targets and whether ISLR- and TIR8-dependent degradation represent a shared mechanism of ubiquitin-independent substrate entry through this alpha subunit.
• No structural model of PSMA4 within the assembled proteasome
• Determinants of substrate specificity uncharacterized
• Whether PSMA4 acts as a general or substrate-specific docking site is unresolved